Paraneoplastic Syndromes in Hodgkin’s Lymphoma
Lymphatics · 2024
DOI: 10.3390/lymphatics2010003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Lymphatics, 2024. Verfasst von Yamna Jadoon und 3 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 99 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Hodgkin’s lymphoma (HL) is a monoclonal lymphoid neoplasm that is mainly characterized by multinucleated Reed–Sternberg cells on a background of non-neoplastic inflammatory cells. The incidence rate of Hodgkin’s lymphoma is 2.5 new cases per 100,000 people per year (1). Paraneoplastic syndromes are conditions that are related to malignancy; however, they are not a result of tumor invasion or compression of malignant tissues. These paraneoplastic syndromes can occur virtually at any point in the disease course, and paraneoplastic syndromes in HL and their various forms are not well studied. In this review article, we will be discussing paraneoplastic syndromes in general and then delve into specific syndromes seen in HL, followed by a brief discourse regarding their early recognition and timely management.
Zitieren
APA
Jadoon, Y., Patil, G., Loke, C., & Bhardwaj, P. V. (2024). Paraneoplastic Syndromes in Hodgkin’s Lymphoma. Lymphatics. https://doi.org/10.3390/lymphatics2010003
Vancouver
Jadoon Y, Patil G, Loke C, Bhardwaj PV. Paraneoplastic Syndromes in Hodgkin’s Lymphoma. Lymphatics. 2024. doi:10.3390/lymphatics2010003
BibTeX
@article{Jadoon2024,
author = {Jadoon, Yamna and Patil, Goutham and Loke, Chandravathi and Bhardwaj, Prarthna V.},
title = {Paraneoplastic Syndromes in Hodgkin’s Lymphoma},
journal = {Lymphatics},
year = {2024},
doi = {10.3390/lymphatics2010003}
}
EUVIMED